New Paths in Human Cancer Serology

New Paths in Human Cancer Serology

T wo questions have dominated the field of human cancer immunology throughout its history. Do cancer-specific antigens exist and, if so, are they recognized by the autologous host? Until recently, attempts to provide definitive answers to these questions have not been rewarded with much success. However, as in so many other areas of research where technical advances provide the means to advance...

Commentary New Paths in Human Cancer Serology By Lloyd

T wo questions have dominated the field of human cancer immunology throughout its history. Do cancer-specific antigens exist and, if so, are they recognized by the autologous host? Until recently, attempts to provide definitive answers to these questions have not been rewarded with much success. However, as in so many other areas of research where technical advances provide the means to advance...

Cryptosporidium Serology in Human Populations

Serology for human papillomavirus.

Difficulties with serology for papillomavirus are associated with the large number of human papillomavirus, cross-reactions between papillomavirus, and to the diversity of lesions and target sites for infection. In addition, the expression of the papillomavirus in the superficial layers of the epithelium gives rise to the weak presentation to immunocompetent cells of viral antigens, which in tu...

New Developments in Blood Group Serology

The last issue of INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN included four articles covering a wide range of developments in serology. These included a review of monoclonal antibodies used in routine and research [1], a study of antibodies to high-frequency red blood cell antigens [2], a contribution to isotypes of cold agglutinins with discussion on the rare occurrence of IgG antibodies to the ...